-
Professor Sizhou Feng: Expert Consensus on the Diagnosis of Infections in Hematology Patients Using mNGS and Its Clinical Application
Patients with hematological disorders are often immunocompromised due to their primary disease or treatment, making them susceptible to infections. These infections often present atypically and can be caused by a wide variety of pathogens. Traditional diagnostic methods have low positivity rates and are time-consuming. Pathogen diagnosis is crucial for optimizing anti-infection treatment and improving patient…
-
Expert Perspective | Professor Jinghang Xu: Fever with Hepatic Damage – Focus on Non-Hepatotropic Viral Hepatitis
Non-hepatotropic viruses are significant pathogens in viral hepatitis. With advancements in diagnostic techniques, cases of hepatitis caused by non-hepatotropic viral infections are increasingly recognized in clinical settings. These viruses can manifest solely as hepatitis or in conjunction with other organ disorders. While most infections cause only mild liver damage, viruses such as HHV-6, Coxsackievirus, and…
-
Professor Qingyuan Zhang: Treatment Strategies for HR+/HER2- Advanced Breast Cancer Patients After Progression on CDK4/6i+ET
While CDK4/6 inhibitors plus endocrine therapy (ET) have become the standard first-line treatment for HR+/HER2- advanced breast cancer patients, there is currently no standardized recommendation for treatment strategies after progression on CDK4/6 inhibitors plus ET. At the “2024 National Breast Cancer Conference,” “Oncology Frontier” had the privilege of inviting Professor Qingyuan Zhang from Harbin Medical…
-
Professor Shaohua Zhang: “CSCO BC Guidelines” Updated, Evidence-Based, Leading Chinese Clinical Practice
The “Chinese Society of Clinical Oncology (CSCO) Breast Cancer Diagnosis and Treatment Guidelines (2024 Edition)” (“CSCO BC Guidelines”) have been updated again, incorporating richer evidence-based medicine from early to late stages, introducing more new treatment strategies and options. It has influenced the field of breast cancer treatment in China significantly. “Oncology Frontier” interviewed Professor Shaohua…
-
BISC 2024 | Professor Xiaomei Tong: Clinical Practice Guidelines for the Use of Meropenem in Treating Neonatal Sepsis (2024 Edition)
Neonatal sepsis refers to the systemic inflammatory response syndrome caused by various pathogens in newborns, ranking as the third leading cause of neonatal mortality globally. Meropenem is one of the most widely used broad-spectrum antibiotics in the treatment of neonatal sepsis. However, its irrational use has led to an increasingly serious problem of bacterial multidrug…
-
2024 National Breast Cancer Congress | Professor Yingying Xu: Reflections on Translational Research Based on Neoadjuvant Platforms
Currently, neoadjuvant therapy has become an optimized treatment modality for locally advanced and some early-stage breast cancers. It can optimize local surgery by downsizing tumors and provide efficacy and prognostic information to guide adjuvant therapy, thus improving survival. Moreover, it serves as an excellent platform for personalized treatment efficacy prediction and new drug development. Translational…
-
BISC 2024 | Professor Wenjie Yang : Rational Use of Oral Antimicrobial Agents in Urinary Tract Infections
Urinary tract infections (UTIs) are commonly encountered in clinical practice, yet their treatment is not as straightforward as many assume. Professor Wenjie Yang from the Department of Infectious Diseases at Tianjin City First Central Hospital begins with epidemiology, etiology, and resistance trends of UTIs, and emphasizes the principles and precautions of treating UTIs with oral…
-
EBMTChina’s Voice| Professor Tong Wu: Innovative Explorations in the Application of Hematopoietic Stem Cell Transplantation Technology
The 50th European Society for Blood and Marrow Transplantation (EBMT) Annual Meeting was held in Glasgow, UK, from April 14th to 17th, 2024. The conference focused on the latest developments in stem cell transplantation and cell therapy, pushing forward better clinical outcomes for patients with hematologic diseases and blood cancers. At this meeting, Dr. Gao’s…
Connecting Medical Expertise through Media